Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy

Gynecol Oncol. 2018 Oct;151(1):1-3. doi: 10.1016/j.ygyno.2018.09.005.

Authors

Weimin Wang¹, Weiping Zou², J Rebecca Liu¹

Affiliations

¹ Department of Surgery, and University of Michigan Roger Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA; Department of Obstetrics and Gynecology, and University of Michigan Roger Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
² Department of Surgery, and University of Michigan Roger Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA; Department of Pathology, and University of Michigan Roger Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA; Center of Excellence for Cancer Immunology and Immunotherapy, and University of Michigan Roger Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Biomarkers, Tumor / immunology
Biomarkers, Tumor / metabolism
Breast / cytology
Breast / pathology
CD8-Positive T-Lymphocytes / immunology*
CD8-Positive T-Lymphocytes / metabolism
CD8-Positive T-Lymphocytes / transplantation
Carcinoma, Ovarian Epithelial
Costimulatory and Inhibitory T-Cell Receptors / antagonists & inhibitors
Costimulatory and Inhibitory T-Cell Receptors / immunology
Costimulatory and Inhibitory T-Cell Receptors / metabolism
Disease-Free Survival
Female
Humans
Immunotherapy / methods*
Lymphocytes, Tumor-Infiltrating / immunology*
Lymphocytes, Tumor-Infiltrating / metabolism
Neoplasms, Glandular and Epithelial / immunology
Neoplasms, Glandular and Epithelial / mortality
Neoplasms, Glandular and Epithelial / pathology
Neoplasms, Glandular and Epithelial / therapy*
Ovarian Neoplasms / immunology
Ovarian Neoplasms / mortality
Ovarian Neoplasms / pathology
Ovarian Neoplasms / therapy*
Prognosis

Substances

Antineoplastic Agents, Immunological
Biomarkers, Tumor
Costimulatory and Inhibitory T-Cell Receptors

Grants and funding